Nanocovax proves immunogenic on all volunteers on 2nd trial phase
	Vietnam's homemade vaccine Nanocovax to enter third human trial phase in May
	COVID-19 vaccine trials: Six volunteers get second shots of Covivac

Medical staff infecting one volunteer in the second phase (Photo: VNE)

Made-in-Vietnam Nanocovax vaccine is set to enter the third phase of human trials at the beginning of June on 13,000 volunteers across the country. Once researchers complete the last phase, expected in late September, the candidate can be mass-produced for vaccine rollout, the Medical Ethics Committee announced Wednesday.

The last stage will trialed in the Hanoi-based Military Medical Academy, Pasteur Institute in Ho Chi Minh City, as well as medical centers in other localities, including Hung Yen, Long An. Authorities will recruit more voluntary recipients while injecting the 800 registered volunteers.

Nanocovax was studied and developed by Nanogen biopharmaceutical company. It requires two doses, 28 days apart to generate maximum antibodies. Results of the last trial phases show the vaccine yields immunity in 100% of volunteers and are effective against the new coronavirus variants from the UK and South Africa.

After the second jab, the antibody levels in some volunteers have reportedly increased by over 60 times compared with after the first injection. Mild post-inoculations such as fever, soreness at injection sites were confirmed, however, all symptoms wore off within hours. There have been no serious side effects.

Deputy Prime Minister Vu Duc Dam, head of the National Steering Committee for COVID-19 Prevention and Control, said he was in stable health condition after receiving the second jab of Nanocovax on March 26.

Deputy Prime Minister Vu Duc Dam gets the second shot of made-in-Vietnam NanoCovax COVID-19 vaccine. (Photo: VOV)

Nanocovax is priced at 5.17 U.S. dollars per dose. Along with injections, it will be developed in the form of eye-drop and nasal sprays for special subjects.

Meanwhile, Covivac, the second indigenous vaccine to enter human trials has completed its first phase and might start the next phase in Thai Binh province, northern Vietnam in late June. IVAC earlier announced one dose of Covivac cost 2.6 U.S. dollars.

Vabiotech’s vaccine is in preclinical testing while Polyvac is studying its candidate in the lab.

Boxes of Nanocovax vaccine (Photo: NanogenPharma)

Vietnam kicked off the nationwide vaccine rollout with British-Swedish AstraZeneca vaccine on March 8. It has received nearly 2.9 million doses, 464,000 through commercial contracts, and the rest through Covax, and vaccinated over a million people so far.

The ministry has deals to buy 30 million doses and obtain 38.9 million doses through the global Covax mechanism. It has also registered to buy 10 million additional doses through Covax under a cost-sharing scheme to benefit from lower prices.

Besides, it has inked a deal to buy 31 million doses of Pfizer’s vaccine this year.

On May 26, the government approved the establishment of a Covid-19 vaccine fund to raise contributions from various sources and ease the burden on its resources. The fund would accept contributions in form of cash and vaccines from benefactors in Vietnam and abroad.

It will be audited by the State Audit Office of Vietnam and the Vietnam Fatherland Front, an umbrella organization of all political and social groups in the country.

Vietnam eyes License of first homegrown Covid-19 Vaccine in Q3 Given the current speed of the Nanocovax vaccine’s human trial, Vietnam is expecting to have the first domestic Covid-19 vaccine greenlighted in late 2021.

Deputy PM gets second shot of homegrown COVID-19 vaccine Deputy Prime Minister Vu Duc Dam on March 26 received the second shot of made-in-Vietnam NanoCovax vaccine, which is on the second trial phase.

Vietnamese volunteers get the second shot of Nano Covax vaccine in second trial phase In the second stage of human trials to test the domestically-produced vaccine, there are 26 volunteers received their second shots of the Nano Covax novel ...